Shenzhen MicroApproach Medical Technology Co., Ltd., found in September 2015 with a registered capital of 30 million yuan, is mainly committed to research, manufacture and merchandize of endovascular medical devices.Their company is a high-tech enterprise in the novel industry of intravascular intervention medical devices, focusing on the development and application of proprietary intellectual rights. Thus, the Shenzhen Science and Technology Innovation Committee awarded their company with a title of “Engineering Technology Center of Endovascular Medical Devices”.
Their company has a strong capacity for research and development, and established a close scientific research collaboration with Beijing Tiantan Hospital, the People's Liberation Army 301 Hospital, Wuhan Tongji Hospital, China Medical University, Shenzhen People's Hospital and other well-known large scientific research institutes. They have also established a first-class R&D group, covering various fields, including neurosurgery,polymer materials, biomedical engineering, immunology and so on.
Their company has always followed the tenet "Quality First & Respect for Life," and served the purpose of "Innovation, Enterprise, Pragmatism, Cooperation and Win-Win" in their company culture. Furthermore, they are committed to provide first-class intravascular intervention products for the majority of medical professionals and patients, and make a contribution for domestic development of endovascular intervention medical devices in China. In order to achieve a large-scale production and standardized management, their company has established a sound management system for medical devices production, and built a state of the art industrial production line for hydrophilic coating guide wire.